ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2016

Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.

Franck Patin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.